Microsoft Word - Source Document Clarinex D12[removed]USPI PPI.doc - Loratadine - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2011-03-08 11:28:44 Piperidines Decongestants Organochlorides Schering-Plough Ketones Desloratadine Loratadine Pseudoephedrine/loratadine Pseudoephedrine Chemistry Organic chemistry Pharmacology		Microsoft Word - Source Document Clarinex D12[removed]USPI PPI.doc Add to Reading List Source URL: www.spfiles.com Download Document from Source Website File Size: 178,06 KB Share Document on Facebook

	35 \| P a g e Antioxidant and inflammatory status of Tunisian patients with chronic spontaneous urticaria and effect of Desloratadine: a case-control study AMAL MAAOUIA , MONIA YOUSSEF , NADIA LEBAN 1 DocID: 1suTI - View Document
	SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Loradis ** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect: DocID: 16VRA - View Document
	SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lorapharm ** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect: DocID: 16NlY - View Document
	SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Allergostad** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect: DocID: 16yDS - View Document
	SYMPOSIUM REPORT SUPPLEMENT Pharmacology of Antihistamines Diana S. Church, MD, and Martin K. Church, PhD, DSc Abstract: This article reviews the molecular biology of the interaction of histamine with its H1-receptor a DocID: 15UWv - View Document